Preface |
|
xi | |
|
1 Prefertilization Events |
|
|
1 | (12) |
|
|
1 | (1) |
|
|
1 | (2) |
|
|
3 | (1) |
|
IV. Consideration of female events |
|
|
4 | (1) |
|
V. Consideration of male events |
|
|
5 | (1) |
|
VI. Clinical considerations |
|
|
6 | (2) |
|
|
8 | (5) |
|
2 Week 1 of Human Development (Days 1-7) |
|
|
13 | (8) |
|
|
13 | (1) |
|
II. Three phases of fertilization |
|
|
13 | (1) |
|
III. Cleavage and blastocyst formation |
|
|
14 | (1) |
|
|
15 | (1) |
|
V. Clinical considerations |
|
|
15 | (2) |
|
|
17 | (4) |
|
3 Week 2 of Human Development (Days 8-14) |
|
|
21 | (8) |
|
I. Further development of the embryoblast |
|
|
21 | (1) |
|
II. Further development of the trophoblast |
|
|
21 | (2) |
|
III. Development of extraembryonic mesoderm |
|
|
23 | (1) |
|
IV. Clinical considerations |
|
|
23 | (2) |
|
|
25 | (4) |
|
4 Embryonic Period (Weeks 3-8) |
|
|
29 | (12) |
|
I. General considerations |
|
|
29 | (1) |
|
II. Further development of the embryoblast |
|
|
29 | (3) |
|
III. Angiogenesis (blood vessel formation) |
|
|
32 | (1) |
|
|
33 | (1) |
|
V. Clinical considerations |
|
|
34 | (1) |
|
VI. Summary of germ layer derivatives |
|
|
35 | (1) |
|
VII. Summary of key events in the embryonic period |
|
|
35 | (3) |
|
|
38 | (3) |
|
|
41 | (24) |
|
I. Development of the heart |
|
|
41 | (13) |
|
II. Development of the arterial system |
|
|
54 | (2) |
|
III. Development of the venous system |
|
|
56 | (2) |
|
|
58 | (7) |
|
6 Placenta and Amniotic Fluid |
|
|
65 | (14) |
|
I. Formation of the placenta |
|
|
65 | (1) |
|
II. Placental components: Decidua basalis and villous chorion |
|
|
65 | (1) |
|
III. Appearance of the placenta in afterbirth |
|
|
65 | (1) |
|
IV. Functions of the placenta |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
VII. Circulatory system of the fetus |
|
|
69 | (2) |
|
|
71 | (1) |
|
IX. Clinical considerations |
|
|
72 | (3) |
|
|
75 | (4) |
|
|
79 | (26) |
|
|
79 | (1) |
|
II. Development of the neural tube |
|
|
79 | (2) |
|
|
81 | (1) |
|
|
81 | (1) |
|
V. Stages of neural tube development |
|
|
81 | (3) |
|
VI. Development of the spinal cord |
|
|
84 | (2) |
|
VII. Development of myelencephalon |
|
|
86 | (2) |
|
VIII. Development of the metencephalon |
|
|
88 | (1) |
|
IX. Development of the mesencephalon |
|
|
89 | (1) |
|
X. Development of the diencephalon, optic structures, and hypophysis |
|
|
90 | (1) |
|
XI. Development of the telencephalon |
|
|
91 | (2) |
|
XII. Development of the autonomic nervous system |
|
|
93 | (1) |
|
XIII. Development of the cranial nerves |
|
|
93 | (1) |
|
XIV. Development of the choroid plexus |
|
|
94 | (1) |
|
XV. Congenital malformations of the central nervous system |
|
|
95 | (5) |
|
|
100 | (5) |
|
|
105 | (8) |
|
|
105 | (1) |
|
|
105 | (3) |
|
|
108 | (1) |
|
|
108 | (1) |
|
V. Congenital malformations of the ear |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (3) |
|
|
113 | (10) |
|
I. Development of the optic vesicle |
|
|
113 | (2) |
|
II. Development of other eye structures |
|
|
115 | (2) |
|
III. Congenital malformations of the eye |
|
|
117 | (2) |
|
|
119 | (1) |
|
|
120 | (3) |
|
|
123 | (16) |
|
|
123 | (1) |
|
II. Derivatives of the foregut |
|
|
123 | (7) |
|
III. Derivatives of the midgut |
|
|
130 | (3) |
|
IV. Derivatives of the hindgut |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
136 | (3) |
|
|
139 | (10) |
|
I. Upper respiratory system |
|
|
139 | (1) |
|
II. Lower respiratory system |
|
|
139 | (6) |
|
|
145 | (4) |
|
|
149 | (14) |
|
|
149 | (3) |
|
II. Development of the thyroid gland |
|
|
152 | (1) |
|
III. Development of the tongue |
|
|
152 | (2) |
|
IV. Development of the mouth |
|
|
154 | (1) |
|
V. Development of the face |
|
|
154 | (1) |
|
VI. Development of the nasal cavities |
|
|
155 | (1) |
|
VII. Development of the palate |
|
|
155 | (1) |
|
VIII. Clinical considerations |
|
|
156 | (3) |
|
|
159 | (4) |
|
|
163 | (12) |
|
|
163 | (1) |
|
II. Development of the kidneys |
|
|
164 | (2) |
|
III. Development of the urinary bladder |
|
|
166 | (1) |
|
IV. Development of the female urethra |
|
|
167 | (1) |
|
V. Development of the male urethra |
|
|
167 | (1) |
|
VI. Development of the suprarenal gland |
|
|
168 | (1) |
|
VII. Clinical considerations |
|
|
169 | (2) |
|
|
171 | (4) |
|
14 Female Reproductive System |
|
|
175 | (8) |
|
I. The indifferent embryo |
|
|
175 | (1) |
|
II. Development of the gonads |
|
|
176 | (1) |
|
III. Development of the genital ducts |
|
|
177 | (1) |
|
IV. Development of the primordia of the external genitalia |
|
|
177 | (2) |
|
V. Clinical considerations |
|
|
179 | (1) |
|
VI. Summary of female reproductive system development |
|
|
180 | (1) |
|
|
181 | (2) |
|
15 Male Reproductive System |
|
|
183 | (10) |
|
I. The indifferent embryo |
|
|
183 | (1) |
|
II. Development of the gonads |
|
|
183 | (2) |
|
III. Development of the genital ducts |
|
|
185 | (1) |
|
IV. Development of the primordia of the external genitalia |
|
|
186 | (1) |
|
V. Clinical considerations |
|
|
187 | (2) |
|
VI. Summary of male reproductive system development |
|
|
189 | (1) |
|
|
190 | (3) |
|
|
193 | (8) |
|
|
193 | (2) |
|
|
195 | (1) |
|
III. Mammary, sweat, and sebaceous glands |
|
|
196 | (1) |
|
|
196 | (3) |
|
|
199 | (2) |
|
|
201 | (12) |
|
|
201 | (2) |
|
|
203 | (5) |
|
|
208 | (1) |
|
|
208 | (1) |
|
V. Bones of the limbs and limb girdles |
|
|
209 | (1) |
|
|
209 | (1) |
|
VII. General skeletal abnormalities |
|
|
210 | (1) |
|
|
211 | (2) |
|
|
213 | (4) |
|
|
213 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (2) |
|
19 Upper Limb Development |
|
|
217 | (10) |
|
I. Upper limb development in general |
|
|
217 | (1) |
|
|
217 | (2) |
|
|
219 | (2) |
|
|
221 | (1) |
|
V. Nerves (Brachia Plexus) |
|
|
222 | (1) |
|
|
223 | (2) |
|
|
225 | (2) |
|
20 Lower Limb Development |
|
|
227 | (10) |
|
I. Lower limb development in general |
|
|
227 | (1) |
|
|
227 | (2) |
|
|
229 | (1) |
|
|
229 | (2) |
|
V. Nerves (lumbosacral plexus) |
|
|
231 | (2) |
|
|
233 | (2) |
|
|
235 | (2) |
|
|
237 | (8) |
|
I. The intraembryonic coelom |
|
|
237 | (2) |
|
II. Positional changes of the diaphragm |
|
|
239 | (1) |
|
III. Clinical considerations |
|
|
239 | (2) |
|
|
241 | (4) |
|
|
245 | (12) |
|
|
245 | (1) |
|
II. Monthly periods of fetal development |
|
|
245 | (3) |
|
III. Factors affecting fetal growth |
|
|
248 | (1) |
|
IV. Viruses that affect the fetus |
|
|
248 | (1) |
|
V. Viability of the fetus |
|
|
249 | (1) |
|
VI. Prenatal diagnostic procedures |
|
|
249 | (3) |
|
|
252 | (5) |
|
|
257 | (12) |
|
I. Introduction-Human birth defects |
|
|
257 | (1) |
|
|
257 | (3) |
|
|
260 | (2) |
|
IV. Drugs, hormones, and chemical agents |
|
|
262 | (2) |
|
|
264 | (1) |
|
|
264 | (2) |
|
|
266 | (3) |
Comprehensive Examination |
|
269 | (18) |
Index |
|
287 | |